secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001326190-24-000022
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune CFO Richard Eisenstadt dies unexpectedly; Andrew Shutterly named acting CFO
--------------------------------------------------------------------------------

- Richard Eisenstadt, CFO, passed away unexpectedly on June 24, 2024.
- Andrew Shutterly appointed acting CFO effective June 25, 2024; previously Corporate Controller since Feb 2023.
- Company has initiated a search for a permanent replacement CFO.
- Shutterly joined Altimmune in Oct 2020 as Assistant Controller; prior roles at Meso Scale Diagnostics and Deloitte.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619024000022/0001326190-24-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619024000022/alt-20240625x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-24-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer